| |

Still beggin’, after all the years…

Seems I’ve spent most of my adult life raising money for one thing or another. Sometimes for personal needs, like the summer I spent as a teen missionary in Brazil, or my recent request for help to do intravenous vitamin C, but more often it’s been for a cause.

This is one of those times. And the Forums at Questioning AIDS is the cause.

When I first started seeking alternatives to the mainstream approach to AIDS that have caused me so much grief, I stumbled up the forums at a site called AIDS Myth Exposed. A few years later, I was a moderator there. A little over two years ago, I helped move those forums to their new home at the appropriately named QuestioningAIDS.com, where I am a member of the management team.

Social networking sites like Facebook are helping to bring more and more of us together as a community like never before. While Facebook emphasizes what’s happening today (more like this afternoon, or maybe just the last 15 minutes), sites like QA provide a rich and searchable database of information going back to 2001.

The forum software that QA is trying to acquire will take advantage of these unique differences and merge the best of both worlds, by allowing people to log on to the QA Forums using their Facebook accounts, for example. Other possibilities include expanding features at QA, such as live chat, or perhaps even user blogs. The first step is to ensure that there is support to continue hosting QA and bringing the software up-to-date.

Before I could even draft this post, the fundraising drive is already more than halfway to reaching its goal of $250, which will be matched by an anonymous donor. But it’s not to late to “ChipIn” a few bucks to a worthy cause.

Those interested can read more about the fundraiser at—where else—the QA Forums here.  Don’t forget that every dollar donated is matched, effectively doubling any contribution made.

Wait... there's more!

  • 97

    97. That’s my latest CD4+ count, less than half the count from six weeks ago.

    That’s it. I have tried as many alternative treatments as I can think of to reverse the decline. I will be starting my third round of pharmaceutical ARVs as soon as I can get a prescription and fill it.

    This decision has been a long time coming, and in hindsight, I probably should have restarted a few months ago. There’s nothing magical about 97, or being below 100, but it’s as good a breaking point as any. I’ve long argued that there are two things to keep in mind about CD4 counts: one is the long-term trend; the other is single- or low double-digit counts.

  • By any other name

    A whole year?! It’s hard to believe that it has been more than a year since I’ve written anything on my blog. I don’t even know how to begin to catch up. I blame Facebook, mostly. I’ve been addicted to the lightning-fast pace of information exchange there, and I’ve written hundreds, maybe even thousands of posts and…

  • Reduce AIDS drug toxicity and side effects

    I embarked on my third course of ARVs since 1998. For ten of the sixteen years I have been HIV-positive, I was able to manage well enough without ARVs and I continue to believe there is no reason for otherwise healthy HIV-positive—let alone negative—gay men to take these drugs. To those who want to wave a recent study about the benefits of early intervention in my face, I would ask them why they put so much faith in a science that has utterly failed us to date.

  • The truth about Truvada: PrEP won’t stop AIDS

    I’m willing to grant that gay men are entitled to use PrEP… provided they have access to all the information they need to make an informed decision. Informed consent has been a hallmark of the HIV and AIDS research and prevention efforts for three decades, and that shouldn’t be waived for the campaign favoring PrEP.

    Gay men deserve to know that all the claims for Truvada reducing the risk of acquiring HIV-positivity  are based on trials—funded by Gilead—that emphasized the importance of using condoms…

Leave a Reply

Your email address will not be published. Required fields are marked *